Pyxis Oncology, Inc
Pyxis Oncology, Inc
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-09-02 | NCT06795412 | |
| A Study of PYX-201 in Advanced Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2026-06-30 | NCT05720117 | |
| Study of PYX-106 in Solid Tumors | Solid Tumor | Active, not recruiting | Phase 1 | 2025-08-03 | NCT05718557 |